Increased risk of everolimus-associated acute kidney injury in cancer patients with impaired kidney function

BACKGROUND: Everolimus was recently introduced as a second-line treatment for renal cell carcinoma (RCC) and many other cancers. Several prospective studies have shown that serum creatinine levels are increased in a significant proportion of patients receiving everolimus. However, data on the occurr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Main Authors: Ha, Sung Hae, Park, Ji Hyeon, Jang, Hye Ryoun, Huh, Wooseong, Lim, Ho-Yeong, Kim, Yoon-Goo, Kim, Dae Joong, Oh, Ha Young, Lee, Jung Eun
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2014
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4265483/
https://ncbi.nlm.nih.gov/pubmed/25466872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-906
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares